Cannabis could be an effective tool to win over voters from both sides of the aisle, so why is Joe Biden hesitant to join the rest of his party and most other Americans? It is popular in key political states, it motivates cannabis supporters to go out and vote and appears to have little political downside. The answer is public health concerns.
States across the country are looking to cannabis to fuel both tax revenue and job growth. The cannabis industry currently employs nearly 250,000 full time jobs – and these numbers only scratch the surface for an industry that remains illegal federally and in nearly 80% of the states.
Governor Cuomo at his 2020 State of the State address last month vowed to legalize Marijuana in New York – citing the effort as a long overdue criminal justice reform. Quickly moving forward with his promise, Cuomo introduced new cannabis legislation as a part of his 2020 budget proposal.
Candidates Overwhelmingly Support Legalization. Plus, Colorado Surpasses $1B in Cannabis Sales in Record Time and Congress Hears Historic Cannabis Reform Testimony from Powerful Coalition of Civil Rights Activists
38 State Attorneys General Sign Letter to Congress Urging Action on SAFE Banking Act
The excitement around investing in cannabis is obvious and undeniable. It shows up in headlines on a daily basis, and investors agree that the time to get involved is before federal legalization normalizes returns, not after. But when will that be? Most will readily say that legalization is going to happen, but very few can tell how or when it will happen. Still fewer can coherently explain the confused, fractured legal status of cannabis at the state level or the many nuanced ways cannabis could experience a de facto legalization that would stimulate huge growth in related capital markets. In this article we outline the myriad political pathways cannabis could take towards legalization, and just how soon it could happen.
Largest-Ever Acquisition in U.S. Cannabis Markets In what will be the largest US-based cannabis acquisition to-date, Chicago-based Cresco Labs has agreed to buy CannaRoyalty in an all-stock transaction valued at $825 million. Cresco stock soared 10% higher and closed at an all-time high, signaling investor support for the deal. This follows on the heels of […]
KEY Investment Partners LLC
1550 Larimer Street, Suite 1084
Denver, Colorado 80202
The information on this website is provided for general informational purposes only and does not constitute an offer to sell, or a solicitation of an offer to buy, any security or investment product. Any such offer or solicitation may be made only by means of definitive offering documents provided to qualified investors. Past performance is not indicative of future results.